Transvaginal Mesh Settlement – Pelvic Mesh Verdicts and Payouts

JP Morgan Chase Bank has agreed to pay $2.5 million dollars in a settlement of claims that it improperly collected fees from customers who had pelvic mesh devices implanted, the U.S. Department of Justice announced Tuesday. The agreement is part of a larger case against JP Morgan Chase and several other financial institutions over allegations they illegally billed more than $1 billion for surgical procedures such as hysterectomies, c-sections and various types of surgery using transvaginal meshes.,

The “mesh settlement updates” is a legal case that has been ongoing for quite some time. The “Pelvic Mesh Verdicts and Payouts” is the verdict from this case.

Transvaginal Mesh Settlement - Pelvic Mesh Verdicts and Payouts

(This page was last updated on April 13, 2018)

More than 100,000 claims have been filed against transvaginal mesh, making it one of the greatest mass torts in history. Many of these claims are still pending, but the multimillion-dollar settlements and judgments that have already been reached auger well for mesh victims waiting for their cases to be settled.

Endo agreed to settle the outstanding cases over its vaginal mesh implants for $775 million.

Furthermore, punitive penalties awarded by jurors in certain cases bolster women’s claims that makers engaged in gross wrongdoing by failing to warn patients about mesh adverse effects.

Endo agreed to pay $775 million to settle the remaining 22,000 claims over their vaginal mesh implants in August 2017.

Please contact us for a free, no-obligation consultation if you or a loved one had significant adverse effects from transvaginal or pelvic mesh. Don’t put it off any longer; some situations are time-sensitive, and you may be due money.

Ethicon/Johnson & Johnson

More vaginal mesh lawsuits have been filed against Johnson & Johnson than any other company. The following are the outcomes of some of the cases that have ruled in mesh sufferers’ favor:

  • Barbara and Anton Kaiser were awarded $35 million by an Indiana jury in March 2018. Barbara Kaiser’s Prolift mesh reportedly caused her pelvic discomfort, therefore they sued Ethicon (a Johnson & Johnson company). They awarded her $10 million in damages and $25 million in punitive penalties against Ethicon.
  • Elizabeth Hrymoc was granted $15 million by a Bergen County, NJ jury in December 2017. Ms. Hrymoc claimed that in 2008, she got a faulty Prolift mesh implant that caused her so much discomfort that she had to have it removed and redone. She sobbed when the jury’s decision was read aloud.
  • Ella Ebaugh claimed she endured severe discomfort and incontinence as a result of two Ethicon pelvic mesh implants that eroded into her urethra, and a Philadelphia jury awarded her $57.1 million in September 2017. The mesh had to be removed three times, according to Ms. Ebaugh. Ethicon has promised to file an appeal.
  • In April 2017, a jury in Philadelphia awarded $20 million to a woman who claimed her TVT-Secur transvaginal mesh, a product of Johnson & Johnson subsidiary Ethicon, caused her chronic suffering. Ethicon said it will appeal the ruling, but it was the company’s sixth significant setback over mesh devices since 2014.
  • Sharon Carlino of New Jersey was awarded $13.5 million in February 2016. Carlino got Ethicon’s transvaginal tape (TVT) for stress urine incontinence, according to the complaint, and it caused her ongoing agony and suffering. Her agony was not relieved by two surgical efforts to repair the device. Punitive damages accounted for $10 million of the judgement. Carlino’s doctor would not have used the Ethicon mesh if the hazards were recognized, according to the verdict.
  • Tessa Taylor, a Florida citizen, received a $4.4 million jury judgment in February 2016. Taylor’s back discomfort, bladder pain, and trouble peeing were caused by the ObTape sling (manufactured by J&J subsidiary Mentor) during a seven-year period, according to the verdict. Taylor got the mesh to cure urine incontinence, but despite the device, she was diagnosed with the disorder again. Punitive penalties of $4 million were awarded to “deter others from acting in a similar manner.”
  • In January 2016, J&J agreed to pay $120 million to resolve 2,000-3,000 mesh cases. The settlement was J&J’s first major effort to resolve a large number of mesh cases. According to a regulatory filing at the time, J&J was still dealing with over 42,000 mesh instances.
  • Patricia Hammons, an Indiana citizen, was granted $12.5 million in damages, including $7 million in punitive penalties. Hammons had the Ethicon Prolift device implanted, and she claims it caused her great pain, sexual issues, and incontinence, even after corrective surgery.
  • Plaintiff Pamela Wicker, who was implanted with Ethicon’s Prolift mesh technology, obtained a $5 million settlement in September. Wicker believes that Prolift destroyed her internal organs, necessitating many procedures to remove it. According to a legal scholar, the huge payment demonstrated that the expenses of dealing with mesh lawsuits will be far greater than anticipated.
  • Coleen Perry was awarded $5.7 million by a California jury in March 2015. Perry had the J&J/Ethicon TVT Abbrevo implanted and expects to be in agony for the rest of her life. The jury determined that the TVT Abbrevo had design flaws and that Ethicon failed to provide adequate warnings regarding possible health concerns. For acts that amounted to “malice,” the jury awarded $5 million in punitive damages.
  • In January 2015, two secret settlements involving 115 mesh victims were completed. The Prolift mesh device was the subject of four lawsuits in Missouri, while the ObTape Transobturator Sling was the subject of 111 cases in Georgia (made by J&J subsidiary Mentor). The ladies from Missouri claimed that the mesh in Ethicon’s Prolift insert shrinks and destroys organs, causing chronic agony and making sexual intercourse impossible, while the women from Georgia claimed that ObTape caused lifelong harm.
  • Plaintiff Jo Husky was granted $3.25 million in a case involving the J&J/Ethicon Gynecare TVT-O mesh implant. After a two-week trial, a West Virginia jury returned the judgment in September 2014. The TVT-O was discovered to be defective, and Ethicon neglected to warn of potential negative effects, according to jurors.
  • Linda Batiste, who was implanted with the Gynecare TVT Obturator (TVT-O) mesh sling (manufactured by J&J subsidiary Ethicon) in April 2013, received a $1.2 million judgment. The jury came to the conclusion that the design of the gadget was defective.
  • Linda Gross of South Dakota received a $11.1 million judgement (including $3.35 million in compensatory damages and $7.76 million in punitive damages) after being implanted with J&J’s Gynecare Prolift vaginal mesh technology. In February 2013, a jury in New Jersey found J&J guilty of deceiving Gross about the device’s hazards.




C.R. Bard

Based in New Jersey, C.R. Bard has made progress in settling some of the vaginal mesh litigation it is facing, but there are still over 10,000 cases pending. The following are some important judgments and settlements:

  • Mary McGinnis, a woman who claims she experienced crippling disabilities as a result of Bard’s pelvic mesh, was awarded $68 million by a New Jersey jury in April 2018. $33 million in compensatory damages and $35 million in punitive damages were awarded by the jury.
  • In August 2015, Bard agreed to pay more than $200 million ($67,000 per case) to resolve an estimated 3,000 instances in their second large-scale mesh settlement. According to legal experts, the settlement was structured to avert a spate of multi-million dollar judgements that may force Bard into bankruptcy.
  • In October 2014, Bard agreed to pay over $21 million to resolve over 500 mesh claims (an average compensation of $43,000 per claim). It was the company’s first large-scale mesh claim resolution.
  • An August 2013 trial resulted in a $2 million judgment. Donna Cisson, the plaintiff, had a device from Bard’s Avaulta family of devices implanted to treat pelvic organ prolapse. Due to discomfort, bleeding, and bladder issues, she underwent many follow-up procedures to remove the mesh. According to Cisson’s attorneys, Bard prioritized profits above patient safety. Punitive damages accounted for $1.75 million of the $2 million total.
  • Elaine Houghton, who had Bard’s Avaulta Plus mesh implant, received a $5.5 million judgment verdict in July 2012. According to reports, Houghton acquired the implant in 2008 and endured nine procedures to treat device-related issues including incontinence and pelvic discomfort. In November 2015, the judgement was lowered to $3.6 million when it was discovered that the doctor was partially to blame.

American Medical Systems/Endo

American Medical Systems Holdings, Inc. (AMS) was bought by Endo International plc (Endo) in 2011. Endo has agreed to pay $2.6 billion to resolve claims that its vaginal mesh devices, such as the Perigee, Apogee, and Elevate implants, caused injuries. AMS transvaginal mesh is no longer manufactured by the business.

Endo’s efforts to address mesh implants manufactured by AMS are seen in the following settlements:

  • In August 2017, a $775 million settlement was reached to resolve 22,000 mesh claims. The remaining litigation against AMS mesh implants will be resolved as a result of this agreement.
  • In April and May 2015, around 450 mesh cases were settled in two different agreements.
  • In October 2014, more than 10,000 mesh claims were settled for $400 million (an average of $48,000 per complaint). Endo claims that the deal has addressed “virtually all” of the outstanding cases against its AMS division. The $400 million was in addition to Endo’s previous commitment of $1.2 billion to address mesh lawsuits.
  • In May 2014, a $830 million settlement was reached to address about 20,000 mesh lawsuits (40,000 per case). The agreement occurred only a day after the FDA announced that transvaginal mesh should be categorized as a high-risk medical device, requiring more stringent regulatory oversight. Endo noted in a statement at the time that “the settlements, if finalized, would address a vast percentage of the AMS vaginal mesh-related claims.”
  • According to a filing with the US Securities and Exchange Commission, $55 million was paid in June 2013 to resolve an unspecified number of cases.




Boston Scientific is a company that specializes in medical

Boston Scientific, situated in Marlborough, Massachusetts, is a leading vaginal mesh maker. After some of the first mesh cases resulted in hefty jury judgments against the manufacturer, including the greatest single verdict of all mesh cases heard so far, Boston Scientific has pushed to settle the remaining cases, but there are still almost 20,000 mesh claims pending.

  • A West Virginia court maintained a $14.3 million jury verdict for three plaintiffs injured by Boston Scientific’s Obtryx pelvic mesh implants in October 2016.
  • Boston Scientific said in October 2015 that it has resolved around 6,000 mesh cases for a total of $457 million in the third quarter of that year. The report, which was based on a filing with the Securities and Exchange Commission, did not provide a breakdown of individual pay per plaintiff.
  • A woman implanted with Boston Scientific’s Pinnacle and Advantage Fit mesh implants was awarded $100 million in May 2015. Although a court ultimately lowered the judgment to $10 million, it was the greatest amount of damages ever awarded in a transvaginal mesh litigation. The complainant argues that the mesh caused her bladder infections and suffering, necessitating remedial operations.
  • In April 2015, $119 million was paid to resolve nearly 3,000 mesh suits (at a cost of $40,000 each case). Boston Scientific said that the settlement deal was struck “solely as a compromise” and that it expected to “vigorously dispute these accusations.”
  • Four ladies who had Boston Scientific’s Obtryx mesh implanted received $18.5 million. The gadgets reportedly caused nerve damage, infection, and painful intercourse for the ladies, who earned between $3.25 and $4.25 million each. The gadgets were judged to be defectively designed and carelessly produced by Boston Scientific by a jury. The decision, handed out on November 20, 2014, was the manufacturer’s second big mesh judgement in a week.
  • Four women who were implanted with the company’s Pinnacle mesh technology received $26.7 million (about $6.5 million each). Plaintiffs say that the devices caused them pain, bleeding, and infection, and attorneys accuse Boston Scientific of failing to fully test the Pinnacle before it went on the market. On November 13, 2014, a decision was made.
  • In September 2014, a jury awarded plaintiff Martha Salazar $73 million. Salazar alleges that the Obtryx sling, which was placed to alleviate urine leaks, has caused chronic nerve damage and persistent pelvic agony. The court ultimately lowered the judgment, which included $50 million in punitive penalties, to $34.5 million.


Coloplast A/S is a Danish medical device company best known for its post-surgical ostomy and urine bags. In a combined federal multidistrict action, the firm is presently facing roughly 2,000 vaginal mesh claims, down from more than 2,400 at its height.

  • In April 2014, Coloplast and roughly 400 vaginal mesh litigants agreed a $16 million settlement. Each claimant will get $40,000 as part of the settlement.


In 2014, Medtronic Inc., one of the three leading medical device manufacturers, decided to purchase Covidien Plc in order to compete with Johnson & Johnson. In a June 2015 SEC filing, Medtronic revealed that its Covidien business was engaged in roughly 11,500 mesh litigation.

  • In 2015, Medtronic put aside $180 million to resolve an undetermined number of mesh complaints.





Neomedic International, based in Coral Gables, Florida, is a Spanish medical equipment manufacturer. Around 130 mesh claims have been filed against the firm, which specializes in pelvic floor goods, as part of a federal mass tort centered in West Virginia.

  • In December 2015, Neomedic paid $2.19 million to resolve an unspecified number of mesh claims. If at least 90% of claimants did not opt into the settlement, Neomedic retained the right to withdraw from the agreement. The Contrasure Needleless Sling System, Needleless Sling System, Remeex System/TRT Remeex System, KIM System, Uplift device, and Surelift device were all covered under the agreement.

Injured? We Can Assist can assist you if you have been affected by transvaginal or pelvic mesh. Our lawyers have helped our clients collect more than $5 billion in damages. To learn more, contact us for a free case evaluation.

Johnson and Johnson has been ordered to pay $105 million in damages and settlements, while the transvaginal mesh settlement will be $1.3 billion. Reference: johnson and johnson mesh lawsuit settlements.

Frequently Asked Questions

Do you have to pay taxes on a mesh settlement?

A: Yes, you are required to pay taxes on any income that is received.

What is the average payout for a hernia mesh lawsuit?

A: The average payout for a hernia mesh lawsuit is around $20,000 USD.

What are the symptoms of pelvic mesh complications?

A: The symptoms of pelvic mesh complications vary depending on the type of mesh you have. In some cases, the only sign or symptom is pain in your groin area that worsens with use and stretches when you move. This can be especially difficult to control as it can affect things like sports or work performance.

Related Tags

  • bladder sling lawsuit settlement amount
  • boston scientific mesh lawsuit update 2021
  • bladder sling lawsuit statute of limitations
  • johnson and johnson mesh lawsuit update 2020
  • transvaginal mesh implant